LOW-DOSE KETOCONAZOLE IN HORMONE REFRACTORY PROSTATE CANCER PATIENTS (HRPC): A SINGLE INSTITUTION EXPERIENCE

被引：0
|
作者：
Romero, J. [1 ]
Rodriguez, A. [1 ,2 ]
Villacampa, F. [1 ]
Duarte, J. M. [1 ]
Cabrera, F. [1 ]
Blanco, M. [1 ]
Sepulveda, J. [2 ]
Rodriguez, A. [1 ,2 ]
Castellano, D. [2 ]
Leiva, O. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Dept Urol, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Oncol, Madrid, Spain
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60056-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [11] Phase II study of single agent gemcitabine in patients with hormone refractory prostate cancer (HRPC).
    Nilsson, S
    Holmberg, M
    Ljung, G
    Pettersson-Skjold, D
    Blom, R
    Ullén, A
    Westberg, R
    Nilsson, I
    Lennernas, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 432S - 432S
  • [12] Metronomic chemotherapy for hormone refractory prostate cancer (HRPC)
    Hoshi, S.
    Numahata, K.
    Hoshi, K.
    Suzuki, K.
    Ono, K.
    Sugano, O.
    Ihidoya, S.
    Saito, S.
    Arai, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [13] SYMPTOM PREVALENCE IN HORMONE REFRACTORY PROSTATE CANCER (HRPC)
    Romanus, D.
    Oh, W. K.
    Cook, F. E.
    Weeks, J. C.
    VALUE IN HEALTH, 2008, 11 (06) : A487 - A487
  • [14] Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
    Nicolini, A
    Mancini, PA
    Ferrari, P
    Anselmi, L
    Tartarelli, G
    Bonazzi, V
    Carpi, A
    Giardino, R
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (08) : 447 - 450
  • [15] Ketoconazole KC with or without doxorubicin DOX in patients pts with chormone refractory prostate cancer HRPC
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 145 - 145
  • [16] Optimized palliative care in hormone refractory prostate cancer (HRPC) patients in advanced age by low dose taxotere therapy and intermittent application
    G., Ludecke
    Hauptmann, A.
    Kohler, E.
    Weidner, W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 100 - 100
  • [17] Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients
    Prezioso, Domenico
    Galasso, Raffaele
    Di Martino, Mario
    Iapicca, Gennaro
    Annunziata, Emanuele
    Iacono, Fabrizio
    ANTICANCER RESEARCH, 2007, 27 (02) : 1095 - 1104
  • [18] Pilot study of rapamycin in hormone refractory prostate cancer (HRPC) patients (Pts).
    Amato, R
    Sharef, S
    Khan, M
    Zhai, QH
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9136S - 9136S
  • [19] Natural history of patients with hormone refractory prostate cancer (HRPC): are they living longer?
    Patel, P.
    Houston, V.
    Hayne, D.
    James, N. D.
    BJU INTERNATIONAL, 2010, 105 : 4 - 4
  • [20] Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer
    Nakabayashi, Mari
    Xie, Wanling
    Regan, Meredith M.
    Jackman, David M.
    Kantoff, Philip W.
    Oh, William K.
    CANCER, 2006, 107 (05) : 975 - 981
12345